MGMT and glioblastoma: Interestingly, several studies have reported varying methylation patterns between de novo and secondary GBM with, for example, promoter methylation of retinoblastoma protein 1 (RB1) and O6-methylguanine methyltransferase (MGMT) being three-fold and two-fold higher in secondary GBM, respectively (11–15).